Single Center Study Regarding Subucutaneous Immunoglobulins for Secondary Immunodeficiencies in Hematological Malignancies

by Catalin | Oct 11, 2024 | 2024 vol. 2 Issue 3

Single Center Study Regarding Subucutaneous Immunoglobulins for Secondary Immunodeficiencies in Hematological Malignancies Daniel Nicolae MURARIU, Sinziana BARBU, Loredana CIRLAN, Larisa ZIDARU, Daniel CORIU, Sorina Nicoleta BADELITA Abstract Purpose: We report a...

Cutaneous Complications after Autologous Stem Cell Transplantation

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Cutaneous Complications after Autologous Stem Cell Transplantation Ana-Maria ILINESCU, Ana-Maria VLADAREANU, Elena Georgiana ENE, Iuliana IORDAN, Horia BUMBEA Autologous stem cell transplantation (ASCT) has become more prevalent for high-grade non-Hodgkin’s...

Real-World Treatment Patterns and Clinical Outcomes in Unfit AML Patients: Results of Current Retrospective Study in Romania

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Real-World Treatment Patterns and Clinical Outcomes in Unfit AML Patients: Results of Current Retrospective Study in Romania Sabina ILUTA, Angela Smaranda DASCALESCU, Alexandra Elena GHIAUR, Ciprian TOMULEASA, Geanina STINGU Aim: The incidence of acute myeloid...

Quantitative BCR::ABL1 Assay Using Digital Real-Time PCR System: Clinical Applications and Insights

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Quantitative BCR::ABL1 Assay Using Digital Real-Time PCR System: Clinical Applications and Insights Madalina CIRNU, Dan-Cristian MARINESCU, Cosmin-Florentin NICULAE, Stefania-Andreea NEGRU, Andreea-Alexandra URECHE-FOTEA, Dan-Sebastian SOARE, Horia BUMBEA, Eugen RADU...

Enhancing Multiple Myeloma Treatment Outcomes with Ixazomib: Insights and Perspectives

by Catalin | Jul 29, 2024 | 2024 vol. 2 Issue 2

Enhancing Multiple Myeloma Treatment Outcomes with Ixazomib: Insights and Perspectives Bianca CONSTANTIN, Sanziana BARBU, Larisa ZIDARU, Loredana CIRLAN, Mihnea GAMAN, Sorina BADELITA Introduction: Multiple myeloma (MM) is a hematologic malignancy characterized by the...